Analyzing Healthcare

Analyzing Healthcare


Can AI Redefine the Economics of Drug Discovery and Healthcare? Rahul Gupta, President, GATC Health x SCALE Community

August 18, 2025

Opioid crisis solutions, AI in drug discovery, precision medicine, healthcare innovation, and policy insights from Dr. Rahul Gupta.


In this episode, Dr. Rahul Gupta, former White House Director of National Drug Control Policy, shares lessons from leading America’s fight against the opioid crisis. He discusses strategies that reversed decades of rising overdose deaths, highlighting the need for accessible treatment and equitable care. Dr. Gupta also introduces his current work with GATC Health, where AI-driven platforms are transforming drug discovery and precision medicine. From predictive analytics to reducing the cost and timeline of clinical trials, his insights reveal how innovation can improve outcomes, lower healthcare costs, and close systemic gaps in care delivery across the U.S.


Title – Can AI Redefine the Economics of Drug Discovery and Healthcare? Rahul Gupta, President, GATC Health x SCALE Community

Key Timestamps:

Key Takeaways:

Guest Bio – Rahul Gupta, President at GATC Health

Dr. Rahul Gupta, one of the nation’s most respected physician-leaders, with a career spanning frontline care, state leadership, and the White House. As Director of National Drug Control Policy, he reversed decades of rising overdose deaths and drove groundbreaking addiction and public health strategies that saved tens of thousands of lives. Today, as Chief Medical Officer at GATC Health, Dr. Gupta is pioneering AI-driven drug discovery and precision medicine, reshaping the economics and future of healthcare.